from PHYLLIS BIRORI in Kigali, Rwanda Rwanda Bureau KIGALI, (CAJ News) – RWANDA is to start manufacturing its own vaccines following a US$2 billion investment on a vaccine plant by Germany-headquartered Biopharmaceutical New Technologies (BioNTech). The facility in the East African country's capital, Kigali, is forecast to make Rwanda and the entire continent self-reliant through